1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Clinical and operative features of pituitary macroadenomas
Hard (5 Cases) Soft (24 Cases) P Value Agea 46.4 ± 20.8 (5) 56.0 ± 16.7 (24) .2687 Sex Male (18) 4 14 .6221 Female (11) 1 10 Preoperative clinical symptoms Visual disturbance (16) 3 13 >.9999 Others (13) 2 11 Headache (6) Hormone abnormality (4) Incidental (3) Clinical endocrine classification Functioning (11) 2 9 >.9999 Nonfunctioning (18) 3 15 Maximum tumor size, mma 27.8 ± 6.4 (5) 29.1 ± 8.9 (24) .7679 Relative postoperative tumor size, %a 72.0 ± 24.4 (4) 28.2 ± 12.1 (23) <.0001
Note:—Numbers in parentheses indicate number of cases in each category.
↵a Data are mean ± SD.